Plasma exchange combined with low-dose rituximab treatment: A case report of severe antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis in the elderly
Rituximab offers a promising therapeutic option for older patients with chronic kidney disease complicated by AAV. Multiple small-dose rituximab regimens may reduce drug-related side effects, significantly lower treatment costs, and provide an effective, economically viable approach for clinical management.
Authors
- Zhen Wu (ORCID: https://orcid.org/0000-0003-1292-5070)
- Qiangguo Ao (ORCID: https://orcid.org/0009-0002-7000-0789)
- Bokai Cheng (ORCID: https://orcid.org/0000-0003-3510-5163)
- Xuwei He
- Zhiying Wang (ORCID: https://orcid.org/0000-0002-7226-1686)
Institutions
- Chinese PLA General Hospital (CN)
Publication Details
- Journal
- Medicine
- Published
- 2025-09-26
- DOI
- https://doi.org/10.1097/md.0000000000044822
- Primary Topic
- Vasculitis and related conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00